Læknablaðið - 15.06.1997, Síða 13

LÆKNABLAÐIÐ 1997; 83
373
HEIMILDIR:
1. Howden CW, Burget DW, Hunt RH, Appropriate acid
suppression for optimal healing of duodenal ulcer and
gastro-oesophageal reflux disease. Scand J Gastroente-
rol 1994; 29/Suppl. 201: 79-82.
2. Bell NJV, Burget DW, Howden CW, Wilkinson J, Hunt
RH. Appropriate acid suppression for the management
of gastro-oesophageal reflux disease. Digestion 1992;
51/Suppl. 1: 59-67.
3. Burget DW, Chiverton SG, Hunt RH. Is there an opti-
mal degree of acid suppression for healing of duodenal
ulcers? A model of the relationship between ulcer heal-
ing and acid suppression. Gastroenterology 1990; 99:
345-51.
4. Chiba N. Rao BV, Rademaker JW, Hunt RH. Meta-
analysis of the efficacy of the antibiotic therapy in erad-
icating H. pylori. Am J Gastroenterol 1992; 87:1716-20.
5. Thors H, Sigurðsson H, Oddsson E, Thjodleifsson B. A
survey of prescriptions for peptic ulcer (ACT class
A02B) in Iceland. Scand J Gastroenterol 1994; 29: 988-
94.
6. Savario V. Mela GS, Scalabrini P, Timoteo ED, Magno-
lia, Celle G. Continuous 24-hour intragastric pH mon-
itoring in the evaluation of the effect of a nightly dose of
famotidine, ranitidine and placebo on gastric acidity of
patients with duodenal ulcer. Digestion 1987; 37:103-9.
7. Hurlimann S, Abbduhl B, Auen W, Halter F. Compari-
son of acid inhibition by either oral high-dose ranitidine
or omeprazole. Aliment Pharmacol Ther 1994; 8: 193-
201.
8. Fimmel CJ, Etienne A, Cilluffo T, Ritter C, Gasser T,
Ray JP, et al. Long-term ambulatory gastric monitoring:
validation of a new method and effect of H,-antagonists.
Gastroenterology 1985; 88: 1842-51.
9. Davidson AG, McCallum A. A survey of the stability of
omeprazole products from 13 countries. Drug Devel-
opement and Industrial Pharmacy 1996; 22: 1173-85.
10. Karlsson A, Lindqvist J, Lövgren K, Rosen L, Tivert
A-M. An investigation of the pharmaceutical quality of
non-Astra authorised omeprazole products - a compara-
tive study. Int Pharm J 1996; 10: 210-4.
11. Rokkas TH, Anggiansah A, Dorrington L, Owen WJ,
Sladen GE. Accurate positioning of the pH probe in the
oesophagus without manometry. Ital J Gastroenterol
1987; 19: 176-8.
12. Emde C, Gardner A, Blum AL. Technical aspects of
intraluminal pH-metry in man: current status and rec-
ommendations. Gut 1987; 28: 1177-88.
13. Mela GS, Savarino V, Malesci A, Di Mario F, Sossai P,
Vigneri S, et al. New method for improving accuracy of
24-hour continuous intragastric pH-metry. Reflections
on physiological and pharmacological studies. Dig Dis
Sci 1994; 39: 1416-24.
14. Mela GS, Savarino V, Vigneri S. Optimizing the in-
formation obtained from continous 24-hour gastric mon-
itoring. Am J Gastroenterol 1992; 87: 961-6.
15. Savarino V, Mela GS, Zentilin P, Scalabrini P, Bonifaci-
no G, Gambaro P, et al. Comparison of the effects of
placebo, ranitidine, famotidine, and nizatidine on in-
tragastric acidity by means of continuos pH recording.
Digestion 1989; 42: 1-6.
16. Oddsson E, Gudjonsson H, Thjodleifsson B. Compari-
son between ranitidine and omeprazole for protection
against gastroduodenal damage caused by naproxen.
Scand J Gastroenterol 1992; 27: 1045-8.